3D Bioprinting Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Inkjet-based
• Magnetic Levitation
• Syringe-based
• Laser-based
• Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Tissue and organ generation
  • Medical pills
  • Prosthetics and implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Bioinks
• Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Bioprinting Market

• Envisiontec, Inc.
• Organovo Holdings, Inc.
• Inventia Life Science PTY LTD
• Poietis
• Vivax Bio, LLC
• Allevi
• Cyfuse Biomedical K.K.
• 3D Bioprinting Solutions
• Cellink Global
• Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Bottled Water Market Trends And Forecast 2021-2028: Grand View Research Inc.

 Bottled Water Market Growth & Trends

The global bottled water market size is expected to reach USD 505.19 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.1% from 2021 to 2028. The growing awareness regarding the adverse health effects of consuming sugary drinks, such as weight gain, obesity, diabetes, and heart disease, is supporting the consumption of alternative beverages, such as still and sparkling water.

The growth of the market is primarily attributed to rising awareness regarding the importance of hydration. According to a study conducted by the International Bottled Water Association in 2018, it was revealed that 93% of American citizens want bottled water to be sold in most stores selling beverages. A substantial part of the population prefers to quench their thirst using bottled water over other beverages.

Increasing preference for nutrient-fortified water is trending owing to the rising importance of health and wellness among buyers. The water demand has been increasing among travelers, working professionals, and for use in households.

COVID-19 has impacted the market for bottled water as many quick-service restaurants have been witnessing a significant drop in their sales. For instance, according to a blog post by CNBC LLC, McDonald’s had witnessed a decline of 22% in March compared to the previous month. COVID-19 compelled the company to shut down its dining rooms.

Request a free sample copy or view report summary: Bottled Water Market Report

Bottled Water Market Report Highlights

• The inclination toward packaged water rather than ordinary water, particularly among younger consumers, drives product sales. Observing this trend, several restaurants are providing bottled water to meet consumer demand
• The purified water segment held the largest share of more than 35.0% in 2020. According to a United Nations study published in 2018, there are almost 16,000 desalination plants across 177 countries that provide purified water
• The sparkling water segment is anticipated to be the fastest-growing segment with a CAGR of 11.7% from 2021 to 2028. Sparkling water is also marketed as sparkling drinking water or sparkling mineral water. Water that contains the same amount of carbon dioxide as its source post-treatment is defined as sparkling water
• Asia Pacific held the largest market share in 2020 and is expected to maintain its lead throughout the forecast period. The regional market is mainly driven by the growing preference for bottled water owing to rising health issues caused by the consumption of contaminated water in countries, including China and India

Bottled Water Market Segmentation

Grand View Research has segmented the global bottled water market on the basis of product and region:

Bottled Water Product Outlook (Revenue, USD Million, 2016 - 2028)

• Spring
• Purified
• Mineral
• Distilled
• Sparkling
• Others

Bottled Water Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • France
• Asia Pacific
  • China
  • India
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Bottled Water Market

• Nestlé SA
• PepsiCo
• The Coca-Cola Company
• DANONE
• Primo Water Corporation
• FIJI Water Company LLC.
• Gerolsteiner Brunnen GmbH & Co. KG
• VOSS WATER
• Nongfu Spring
• Rhodius Mineralquellen Und Getranke GmbH & Co KG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Digital Pathology Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 North America Digital Pathology Market Growth & Trends          

The North America digital pathology market size is expected to reach USD 593.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

Request a free sample copy or view report summary: North America Digital Pathology Market Report

North America Digital Pathology Market Report Highlights

• The software segment is anticipated to witness a lucrative growth rate of 6.8% in the coming years. The segment is inclusive of pathology workflow management solution and LIMS software
• This software is simple to install and use, easy to obtain specific patient information, and efficiently and quickly sends reports digitally to pathologists and clinicians. Owing to these associated advantages the software segment is expected to witness lucrative growth over the forecast period
• The practice of sharing digital imagery across labs helps in accelerating drug discovery and development processes by enabling pathologists to effectively analyze records and communicate and collaborate on crucial result findings in tissue-based efficacy studies
• The disease diagnosis segment is projected to witness a significant CAGR of 7.0% in the coming years as the FDA approved the practice of sharing digital imagery across labs for primary diagnosis applications such as cancer cell detection
• Diagnostic laboratories are expected to witness lucrative growth of 7.1% over the forecast period owing to the rising incidence of cancer in this region. Moreover, the implementation of digital pathology solutions and devices is likely to help improve laboratory workflow efficiency, accuracy, and quality of disease diagnosis using computational pathology
• Competitive rivalry in the market is expected to remain high over the forecast period. The market is dominated by few players such as Philips and Leica Biosystems that hold a majority of the revenue
• The strategies implemented by these players are product differentiation, new product launch, collaboration, merger, and acquisition to gain a larger share of the market

North America Digital Pathology Market Segmentation

Grand View Research has segmented the North America digital pathology market on the basis of the product, application, end use, and country:

North America Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Device

North America Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery & Development
• Academic Research
• Disease Diagnosis
  • Cancer Cell Detection
  • Others

North America Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Cancer Hospitals
• Diagnostic Labs
• Academic & Research Institutes

North America Digital Pathology Country Outlook (Revenue, USD Million, 2016 - 2028)

• US.
• Canada

List of Key Players of North America Digital Pathology Market

• Leica Biosystems
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Hoffmann-La Roche Ltd
• Mikroscan Technologies
• 3DHISTECH Ltd.
• Inspirata, Inc.
• Visiopharm A/S
• Huron Technologies International, Inc.
• Sectra AB

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Contract Manufacturing Market Strong Application and Emerging Trends also Scope by 2028: Grand View Research Inc.

 Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 323.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.7% from 2021 to 2028. The changing regulatory landscape, coupled with rising offshoring to emerging countries, is anticipated to propel the market growth over the forecast period.

Increasing demand for advanced products is a major factor driving the market. Original equipment manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly to developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions, such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Moreover, the growing geriatric population across the globe and the consequent rise in age-related diseases have stimulated the progress of pharmaceutical and medical device development, thus leading to the growth of the healthcare manufacturing industry. With a rise in demand, the market now witnesses an influx of manufacturing service providers. Asia Pacific was the dominant regional market for medical device outsourcing in 2020 owing to lower cost and easy availability of skilled human resources. For instance, according to IBEF, M&A deals in the healthcare sector in India increased by 155% (USD 1.09 billion) in 2019.

A rise in the number of medical device companies vying to enter regional markets, such as India and China, is further expected to contribute to the growth of this market. For instance, the Chinese government’s Marketing Authorization Holder (MAH) scheme facilitates international healthcare players to produce their products within the local Chinese market equipped with state-of-the-art centers. The expansion of production capacity by players such as WuxiBiologics is a distinguished example of this deliberate plan.

Due to the emergence of infections, such as COVD-19, many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on a large scale. Hence, we can say that the pandemic has had a positive impact on this industry.

This paradigm shift from in-house manufacturing to contract manufacturing in the pharmaceutical and medical device industry has resulted in the increased focus of the companies on contract manufacturing service vendors. These services have effectively addressed the concerns regarding pharmaceutical and medical device manufacturing as well as significantly accelerated the commercialization of products.

Request a free sample copy or view report summary: Healthcare Contract Manufacturing Market Report

Healthcare Contract Manufacturing Market Report Highlights

• By type, the pharmaceutical segment dominated the market with a share of 75.2% in 2020 owing to low manufacturing budget and highly sophisticated contract manufacturing service offerings
• The medical device type segment is expected to be the fastest-growing segment with a CAGR of 9.7% over the forecast period owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
• Cardiology was the dominant therapeutic area segment in the medical device contract manufacturing market in 2020 owing to rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
• Asia Pacific dominated the market in 2020 and is expected to witness the fastest growth over the forecast period owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region

Healthcare Contract Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare contract manufacturing market based on type and region:

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Billion, 2016 - 2028)

• Medical Device        
  • By Service
    • Accessories Manufacturing
    • Assembly Manufacturing
    • Component Manufacturing
    • Device Manufacturing
  • By Therapeutic Area
    • Cardiology
    • Diagnostic Imaging
    • Orthopedic
    • IVD
    • Ophthalmic
    • General & Plastic Surgery
    • Drug Delivery
    • Dental
    • Endoscopy
    • Diabetes Care
    • Others
  • Pharmaceutical
    • By Service
      • API/Bulk Drugs
      • Advanced Drug Delivery Formulations
      • Packaging
      • Finished Dose Formulations
        • Solid
        • Liquid
        • Semi-solid Formulations

Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Belgium
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

List of Key Players of Healthcare Contract Manufacturing Market

• Nordson Corporation
• Integer Holdings Corporation
• Jabil Inc.
• Viant Technology LLC
• FLEX LTD.
• Celestica Inc.
• Sanmina Corporation
• Plexus Corp.
• Phillips-Medisize
• Synecco
• Catalent, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biobanks Market To Hold a High Potential for Growth by 2028: Grand View Research Inc.

 Biobanks Market Growth & Trends

The global biobanks market size is expected to reach USD 106.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Biobanks continue to evolve with the introduction of new technologies such as NGS and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market.

The quality of biospecimens can significantly influence the disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples. For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples.

This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

Request a free sample copy or view report summary: Biobanks Market Report

Biobanks Market Report Highlights

• The biobanking equipment segment accounted for the maximum revenue share in 2020 owing to the high cost of instruments coupled with an increase in the number of biorepositories
• The biobanking and repository services segment accounted for the largest revenue share of 36.0% in the market
• This is because of the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicineand disease-specific research
• Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
• The virtual biobanks segment is anticipated to witness the fastest growth rate over the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
• The therapeutics application segment accounted for the largest revenue share in 2020 owing to the growing popularity of cell therapies for cancer treatment
• Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment
• North America dominated the market with its wide network of centers for biosample storage in the U.S.
• Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving the revenue in North America
• In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across the Asian countries
• The key players are engaged in expanding their global reach by partnering with global distributors, merger, and acquisition of other players, and entering a strategic alliance with research communities

Biobanks Market Segmentation

Grand View Research has segmented the global biobanks market on the basis of product, service, biospecimen type, biobanks type, application, and region:

Biobanks Product Outlook (Revenue, USD Million, 2017 - 2028)

• Biobanking Equipment
  • Temperature Control Systems
    • Freezers & Refrigerators
    • Cryogenic Storage Systems
    • Thawing Equipment
  • Incubators & Centrifuges
  • Alarms & Monitoring Systems
  • Accessories & Other Equipment
• Biobanking Consumables
• Laboratory Information Management Systems

Biobanks Service Outlook (Revenue, USD Million, 2017 - 2028)

• Biobanking & Repository
• Lab processing
• Qualification/ Validation
• Cold Chain Logistics
• Other Services

Biobanks Biospecimen Type Outlook (Revenue, USD Million, 2017 - 2028)

• Human Tissues
• Organs
• Stem Cells
  • Adult Stem Cells
  • Embryonic Stem Cells
  • IPS Cells
  • Other Stem Cells
• Other Biospecimens

Biobanks Type Outlook (Revenue, USD Million, 2017 - 2028)

• Physical/Real Biobanks
  • Tissue Biobanks
  • Population Based Biobanks
  • Genetic (DNA/RNA)
  • Disease Based Biobanks
• Virtual Biobanks

Biobanks Application Outlook (Revenue, USD Million, 2017 - 2028)

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics
• Other Applications

Biobanks Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Biobanks Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• QIAGEN
• Hamilton Company
• Avantor
• Tecan Trading AG.
• Danaher Corporation
• Becton, Dickinson and Company (BD)
• BioCision
• Taylor-Wharton
• Charles River Laboratories
• Lonza
• STEMCELL Technologies Inc.
• Biovault Family
• PromoCell GmbH
• Precision Cellular Storage Ltd. (Virgin Health Bank)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Cell Culture Market to Bring In USD 3.48 Billion by End of the Forecast Period

 3D Cell Culture Market Growth & Trends

The global 3D cell culture market size is expected to reach USD 3.48 billion by 2028 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.

As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.

Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.

Request a free sample copy or view report summary: 3D Cell Culture Market Report

3D Cell Culture Market Report Highlights

• The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
• Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
• Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
• Cancer was the largest application segment of the market in 2020. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
• Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
• Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
• Biotechnology and pharmaceutical organizations accounted for the largest share in 2020 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
• Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
• North America led the market in 2020 owing to extensive usage of 3D cell culture models for medical research purposes
• In April 2020, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
• Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 due to rising investments by North American and European companies in APAC regional market
• The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
• For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration

3D Cell Culture Market Segmentation

Grand View Research has segmented the global 3D cell culture market on the basis of technology, application, end use, and region:

3D Cell Culture Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Scaffold-based
  • Hydrogels
  • Polymeric Scaffolds
  • Micro-patterned Surface Microplates
  • Nanofiber-based Scaffolds
• Scaffold-free
  • Hanging Drop Microplates
  • Microfluidic 3D Cell Culture
  • Spheroid Microplates with ULA coating
  • Magnetic Levitation & 3D Bioprinting
• Bioreactors

3D Cell Culture Application Outlook (Revenue, USD Million, 2016 - 2028)

• Cancer
• Tissue Engineering & Immunohistochemistry
• Drug Development
• Stem Cell Research
• Others

3D Cell Culture End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Biotechnology and Pharmaceutical Industries
• Research Laboratories and Institutes
• Hospitals and Diagnostic Centers
• Others

3D Cell Culture Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• MEA
  • South Africa

List of Key Players of 3D Cell Culture Market

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• PromoCell GmbH
• Greiner Bio One International GmbH
• Corning, Inc.
• 3D Biomatrix
• Lonza
• Avantor Performance Materials, LLC
• Tecan Trading AG
• 3D Biotek LLC
• Global Cell Solutions, Inc.
• InSphero

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Point Of Care Diagnostics & Testing Market is Anticipated to Upgrade USD 35.74 Billion Revenue By 2028

 Point Of Care Diagnostics & Testing Market Growth & Trends

The global point of care diagnostics & testing market size is estimated to reach USD 35.74 billion by 2028, registering a CAGR of 3.25%, according to a new report by Grand View Research, Inc. Point of care (POC) diagnostics & testing has significantly altered the therapeutic models applied for the treatment of diabetic patients, HIV patients, and patients with Cardiovascular Disorders (CVDs), in recent years. In addition, emerging advancements on the horizon are projected to enhance the near-patient treatment workflows for infectious diseases, strokes, and cancer.

The industry is set to witness lucrative growth as POC testing serves as a profitable alternative to traditional laboratory tests. Point-of-care devices are designed to offer actionable information at the location and time of patient care, which enables early diagnosis of diseases. The advent of non-invasive & minimally invasive POC devices, continuous POCT, miniaturized technologies, and the adoption of telemedicine in remote patient monitoring are some of the key trends contributing to the market growth.

Moreover, the advent of rapid data sharing solutions as well as platforms is set to contribute to the development of POC COVID-19 tests, supplementing the overall market growth. Companies actively working toward the development of such rapid data sharing solutions include Foundation for Innovative New Diagnostics (FIND) and 360 Dx. The rising number of such companies is set to offer manufacturers/developers and professionals a clear perspective with respect to the future opportunities associated with POC COVID-19 tests.

The development of multiplex POC diagnostic technologies that enable the detection of multiple infectious pathogens in specimens, such as sputum, urine, or blood, offers improved patient outcomes and better disease diagnosis. The wide adoption of multiplex POC devices is anticipated to serve as a driver for the shift in preference from a centralized disease testing model to a decentralized patient-centered model.

Major companies are initiating strategic product launches to strengthen their market presence. For instance, in October 2020, Roche announced the launch of the Elecsys SARS-CoV-2 Antigen test that supports COVID-19 testing of suspected patients at high volumes. In April 2020, Nova Biomedical introduced PT/INR testing for its Allegro capillary blood analyzer to be used in POC primary care settings. This test is available in CE-regulated countries.

PR/INR is among the total 18 tests of the Allegro platform and is designed to measure HbA1c, hemoglobin, cholesterol, glucose, triglycerides, UACR, creatinine, hematocrit, and uric acid. This product expanded the testing portfolio of the company’s Allergo platform.

Request a free sample copy or view report summary: Point Of Care Diagnostics & Testing Market Report

Point of Care Diagnostics & Testing Market Report Highlights

• The glucose testing product segment led the market in 2020 due to high demand for POC glucose monitors for routine glucose testing as a result of an increased number of diabetic patients across the globe
• The infectious disease product segment is expected to account for the highest revenue share by 2028. This growth is majorly attributed to the global COVID-19 pandemic
• The first POC diagnostic test for COVID-19 was approved by the U.S. FDA in March 2020 under Emergency Use Authorization, which was manufactured by Cepheid
• Since then, key players in this market are engaged in developing and manufacturing such tests, which, in turn, is boosting the segment growth
• The clinics end-use segment accounted for the dominant revenue share in 2020 and will expand further at a steady CAGR from 2021 to 2028 owing to increasing transition from conventional lab testing to POCT by healthcare professionals to shorten the time taken for diagnosis and further treatments
• Led by the U.S., North America was the leading regional market in 2020 and held a revenue share of more than 34%

Point Of Care Diagnostics & Testing Market Segmentation

Grand View Research has segmented the global point of care diagnostics & testing market on the basis of product, end-use, and region:

POC Diagnostics & Testing Product Outlook (Revenue, USD Million, 2017 - 2028)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
  • HIV
  • Clostridium Difficile
  • HBV
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV)
  • HPV
  • Influenza/Flu
  • HCV
  • MRSA
  • TB and Drug-Resistant TB
  • HSV
  • COVID-19
  • Other Infectious Diseases
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

POC Diagnostics & Testing End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Clinics
  • Pharmacy & Retail Clinics
  • Physician Office
  • Urgent Care Clinics
  • Non-practice Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

POC Diagnostics & Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of POC Diagnostics & Testing Market

• Hoffmann-La Roche Ltd.
• Qiagen
• Danaher Corp.
• Becton Dickinson (BD)
• Biomerieux SA
• Abbott Laboratories
• Siemens Healthcare AG
• Zoetis, Inc.
• Instrumentation Laboratory
• Nova Biomedical
• Trividia Health, Inc.
• Quidel Corp.
• Trinity Biotech
• Sekisui Diagnostics
• Orasure Technologies, Inc.
• Nipro Corp.
• Spectral Medical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Product Design & Development Services Market Current And Future Market Conditions 2021-2028: Grand View Research Inc.

 Product Design And Development Services Market Growth & Trends

The global product design and development services market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Low product cost, short time-to-market, and demand for advanced technologies are some of the factors boosting the growth. Medical and life sciences companies face extreme cost pressures to develop new and innovative products in shorter time frames while complying with stringent regulatory requirements of medical device.

The manufacturers face more hurdles in getting cost-effective high-quality products to market faster along with some internal factors, such as designing and production. Hence, medical device companies adopt a design-to-manufacturing approach where design, engineering, as well as production teams work in collaboration to develop the product model. This approach enhances both product quality and profitability by decreasing errors in development and designing thereby increasing success rates.

Outsourcing design engineering is anticipated to witness healthy growth over the forecast period as an increased number of manufacturers—from start-up ventures to established companies—capitalize on the benefits related to outsourcing design engineering such as improved product design and cost-effectiveness to attain a competitive edge. Furthermore, with the incorporation of IT into healthcare industry, analysis on 3D models and software, for which the third parties are well trained are expected to promote growth.

However, COVID-19 has added complexity and challenge to the medical device innovation. The product development firms are facing the major challenges so far as how to continue with business operations while evading the effects of the crisis. Product development during the pandemic continues to show optimal scope. The huge cost of development, financial risks of missing the mark, and market timing altogether contribute to the greatest challenges of medical device development and market driving innovation.

Request a free sample copy or view report summary: Product Design And Development Services Market Report

Product Design & Development Services Market Report Highlights

• The research, strategy, and concept generation services segment accounted for the highest revenue share of 39.9% in 2020 as the stage requires extensive research and business and design strategy that generate maximum revenue
• The surgical instruments segment held major market share of 27.9% in 2020, due to the complexity of instruments which require detailed designing for making them suitable for direct contact with human body
• Key players in emerging economies of Asia Pacific and Latin America are witnessing significant increase in their revenue owing to the presence of lucrative growth opportunities
• Medical device Original Equipment Manufacturers (OEMs) are outsourcing the production of their devices to developing economies due to availability of labor and raw materials at affordable cost

Product Design & Development Services Market Segmentation

Grand View Research has segmented the global product design and development services market based on services, application, end use, and region:

Product Design And Development Services Outlook (Revenue, USD Million, 2016 - 2028)

• Research, Strategy, & Concept Generation
• Concept & Requirements Development
• Detailed Design & Process Development
• Design Verification
• Process Validation, Manufacturing Transfer & Design Validation
• Production & Commercial Support

Product Design And Development Services Application Outlook (Revenue, USD Million, 2016 - 2028)

• Diagnostic Equipment
• Therapeutic Equipment
• Surgical Instruments
• Clinical Laboratory Equipment
• Biological Storage
• Consumables
• Others

Product Design And Development Services End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations

Product Design And Development Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Ukraine
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South KoreaIndonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

List of Key Players of Product Design And Development Services Market

• Ximedica
• DeviceLab Inc.
• Jabil Inc.
• Flex Ltd.
• Plexus Corp.
• Celestica Inc.
• Starfish Medical
• Nordson Medical
• Planet Innovation
• Donatelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Transplantation Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 26.5 billion by 2028, growing at a CAGR of 11.5%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in high demand for transplantation procedures, which is boosting the market growth. Rising demand for transplant products, such as tissue products, immunosuppressants, and organ preservation solutions, is also a major factor driving the market. Many biotechnology and medical device companies are concentrating on the development of advanced transplant products for the management of organ failure.

Thus, technological advancement and the development of novel & improved transplant products, such as surgical instruments, have majorly contributed to the expansion of the market. In addition, the introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane, provides higher benefits during treatment. Furthermore, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports market growth.

Request a free sample copy or view report summary: Transplantation Market Report

Transplantation Market Report Highlights

• The tissue products segment accounted for the largest revenue share in 2020 due to increased demand for tissue and organ transplant procedures
• The tissue products segment is expected to expand further at a significant CAGR from 2021 to 2028 owing to the advancements in transplantation products
• The tissue transplant segment held the largest revenue share in 2020 on account of the high demand for tissue transplant procedures worldwide
• The transplant centers segment is projected to record the fastest CAGR during the forecast period owing to the rising popularity of these centers for transplant procedures
• The hospitals segment dominated the market, in terms of revenue share, in 2020 owing to a large number of transplant procedures performed in hospitals
• North America was the leading regional market in 2020 and is projected to maintain its dominance during the forecast period owing to the presence of well-developed healthcare infrastructure in the region
• The presence of a large number of research laboratories, biotechnology, and medical device companies inNorth America is also one of the key factors contributing to the region’s growth

Transplantation Market Segmentation

Grand View Research has segmented the global transplantation market on the basis of product type, application type, end-use, and region:

Transplantation Product Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

Transplantation Application Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Organ Transplant
• Tissue Transplant

Transplantation End-use Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Hospitals
• Transplant Centers
• Others

Transplantation Regional Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Transplantation Market

• Stryker Corp.
• Medtronic PLC
• AbbVie Inc.
• Zimmer Biomet
• Novartis International AG
• 21st Century Medicine
• Biolife Solutions
• Teva Pharmaceutical
• Veloxis Pharmaceuticals

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sex Toys Market to Reach Around $52.39 Billion by 2028: Grand View Research Inc.

Sex Toys Market Growth & Trends

The global sex toys market size is expected to reach USD 52.39 billion by 2028, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.04% during the forecast period. Women aging from 16 to 70 years old are indulging in the pleasure of adult toys. The stigma of using these products to replace a partner has long been broken by couples who enjoy these toys from time to time, which is expected to drive the market growth.

The impact of the COVID-19 pandemic is expected to create an economic downturn in all industries as the majority of countries are in lockdown. However, the initial impact of country-wide lockdown has exhibited a boost in sales of sex toys. Several countries such as Italy, the U.S., Australia, U.K., Canada, and France reported high demand for sex toys, from January to March 2020. These countries have also experienced increased sales, from the anticipated yearly forecast. People are advised to practice social distancing and self-isolation for self-care, which has led to an increase in the sales of sex toys such as vibrators and massagers.LELO launched a wave of Stayhome and Save deals applicable for the entire month of May 2020, wherein the company was offering up to 15% discounts on its products.

Asia Pacific is expected to be the fastest-growing market during the forecast period. China and Australia are the leading revenue generators in the market. The stigma surrounding sex is reducing among millennials and Gen-Z, who are more open to exploring new things to enhance their sexual experience.In March 2019, Reckitt Benckiser launched its direct-to-consumer e-commerce platform to sell its premium products in India.

Request a free sample copy or view report summary: Sex Toys Market Report

Sex Toys Market Report Highlights

• The female sex toys segment held the largest market share in 2020 and is expected to expand at the second-highest CAGR during the forecast period. Single women are among the leading contributors to the market growth
• Manufacturers are trying to reach a larger market via e-commerce sites. In developing countries where adult stores are not easily accessible, online retailers are meeting customer demand by offering a different range of products via discrete delivery and an added advantage of discounted rates
• North America held the largest market share in 2020, owing to the presence of numerous retailers providing easy access to products. In the U.S. and Canada, sociodemographic factors also play a role in the type of toy being preferred and its frequency of use
• With increasing disposable income in developing countries, consumers are opting for innovative products such as exquisite vibrators, BDSM gear, and anal toys. This increases opportunities for market players to capitalize on the growing demand for more high-end innovative products
• Emerging players backed by technological advancements are developing products that offer a more realistic experience. Brand leaders such as Doc Johnson, LELO, FleshLight, and LoveHoney have a global presence with a strong product portfolio.In July 2019, LifeStyles Healthcare announced the launch of three new intimate accessories under its SKYN brand-SKYN Thrill, SKYN Vibes, and SKYN Shiver

Sex Toys Market Segmentation

Grand View Research has segmented the global sex toys market based on type, distribution channel, and region:

Sex Toys Type Outlook (Revenue, USD Million, 2016 - 2028)

• Female
• Male

Sex Toys Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• E-commerce
• Specialty Stores
• Mass Merchandizers

Sex Toys Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Australia
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of the Sex Toys Market

• Church & Dwight Co., Inc.
• Reckitt Benckiser Group plc
• LELO
• LifeStyles Healthcare Pte Ltd
• Doc Johnson Enterprises
• Lovehoney Group Ltd
• BMS Factory
• PinkCherry
• Tenga Co., Ltd.
• Fun Factory
• We-Vibe

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. 

Craniomaxillofacial Devices Market Trends Regulations And Competitive Landscape Outlook to 2028

 Craniomaxillofacial Devices Market Growth & Trends

The global craniomaxillofacial devices market size is expected to reach USD 3.2 billion by 2028 registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Craniofacial surgery treats conditions that affect the head, skull, face, and neck. The rise in the number of facial and head injuries caused due to road accidents and increasing cases of sports-related injuries are expected to boost demand for craniomaxillofacial (CMF) devices.

Growingpreferencefor minimally invasive surgeries is also one of the key factors expected to support market growth. Organizations, such as the American Society of Craniofacial Surgery (ASCFS) and the International Society of Craniofacial Surgery (ISCFS), are conducting a research program in a probe to increase awareness of CMF surgeries, boosting consumer awareness about the craniomaxillofacial devices. This is also projected to help boost the overall market growth.

Neck injuries are one of the most common types of injuries in vehicle accidents. Over 800, 000 cases of vehicle crashes involving neck injuries are reported per year in the U.S. Moreover, sports injuries, car accidents, and falls were some of the leading causes of head injuries in the country. Hence, the U.S. is expected to be a potential market for CMF device manufacturers. The global pandemic has led to the cancellation and rescheduling of surgical procedures, which will hamper the market growth to some extent.

Request a free sample copy or view report summary: Craniomaxillofacial Devices Market Report

Craniomaxillofacial Devices Market Report Highlights

• In 2020, the CMF plate and screw fixation segment led the global market due to the rise in the number of surgeries requiring bone stabilization
• The bioabsorbable material segment is estimated to register the fastest CAGR during the forecasted period due to technological advancements
• Neurosurgery & ENT is expected to be the fastest-growing application segment from 2021 to 2028 due to an increase in the volume of surgical procedures pertaining to trauma and the adoption of deep brain stimulation procedures
• Latin American region is projected to be the fastest-growing regional market during the forecast period on account of rising cases of accidents in Brazil and Mexico

Craniomaxillofacial Devices Market Segmentation

Grand View Research has segmented the global craniomaxillofacial devices market on the basis of product, material, application, and region:

CMF Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Cranial Flap Fixation
• CMF Distraction
• Temporomandibular Joint Replacement
• Thoracic Fixation
• Bone Graft Substitute
• CMF Plate & Screw Fixation

CMF Devices Material Outlook (Revenue, USD Million, 2016 - 2028)

• Metal
• Bioabsorbable Material
• Ceramics

CMF Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Neurosurgery & ENT
• Orthognathic & Dental Surgery
• Plastic Surgery

CMF Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Malaysia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Craniomaxillofacial Devices Market

• DePuy Synthes (J&J)
• Stryker Corp.
• Medtronic plc
• Zimmer Biomet

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Brain Health Supplements Market is Thriving USD 13.38 Billion Revenue by 2028: Grand View Research Inc.

 Brain Health Supplements Market Growth & Trends

The global brain health supplements market size is expected to reach USD 13.38 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2021 to 2028. The rising awareness among consumers regarding mental health is fueling the adoption of supplements over the world. The increasing brain health issues, such as depression and dementia, boost the demand for the products. Depression, stress, and anxiety are common mental illnesses among adolescents and millennials. Furthermore, the COVID-19 pandemic has heightened the occurrence of these mental illnesses over the world and boosted the demand for brain health supplements.

Natural molecules accounted for the largest market share in 2020. The expansion of this segment is attributed to the easy availability and cost-effectiveness of the products. The natural ingredients in these products, including omega-3 fatty acids, Huperzine-A, and Acetyl-L-carnitine, help in improving the focus and easing stress, anxiety, and depression. Herbal extract products are expected to expand at the fastest CAGR of 9.2% from 2021 to 2028.

The supplements for memory enhancement dominated the market in 2020, with more than 25.0% revenue share due to the increased number of Alzheimer's patients worldwide. According to the Alzheimer's Association, as of 2020, around 5.8 million people in the U.S. had Alzheimer's. The growing number of the aging population has been driving the demand for memory enhancement supplements as memory loss is a widespread illness among the older population.

The industry is competitive with a large number of large and medium-sized firms across the globe. New product launches are expected to remain a key trend in the industry. In April 2019, Reckitt Benckiser Group plc. introduced Neuriva supplement, with complimentary digital support and training program. The product is designed to improve cognitive functions, including focus, memory, and consumers' concentration.

Request a free sample copy or view report summary: Brain Health Supplements Market Report

Brain Health Supplements Market Report Highlights

• By product, the herbal extract segment is expected to register the fastest CAGR of 9.2% from 2021 to 2028 owing to the increasing preference for herbal products among the consumers
• North America dominated the market with over 35.0% revenue share in 2020. Increased concerns about brain health, along with the expanded prevalence of Alzheimer's among elderly people, have been boosting the market growth in the region
• The memory enhancement application segment held the largest share of more than 25.0% in 2020

Brain Health Supplements Market Segmentation

Grand View Research has segmented the global brain health supplements market on the basis of product, application, and region:

Brain Health Supplements Product Outlook (Revenue, USD Million, 2016 - 2028)

• Natural Molecules
• Herbal Extract
• Vitamins & Minerals

Brain Health Supplements Application Outlook (Revenue, USD Million, 2016 - 2028)

• Memory Enhancement
• Attention & Focus
• Depression & Mood
• Sleep & Recovery
• Anti-aging & Longevity
• Stress & Anxiety

Brain Health Supplements Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

List of Key Players of Brain Health Supplements Market

• Teva Pharmaceutical Industries Ltd.
• HVMN Inc.
• Purelife Bioscience Co., Ltd.
• Peak Nootropics
• AlternaScript
• Liquid Health, Inc.
• Natural Factors Nutritional Products Ltd.
• Reckitt Benckiser Group plc.
• Onnit Labs, Inc.
• Quincy Bioscience

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Eyewear Market to Reflect a Holistic Expansion During 2021 to 2028

 Eyewear Market Growth & Trends

The global eyewear market size is anticipated to reach USD 278.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to exhibit a CAGR of 8.5% during the forecast period. Advancements in lens-making technology enable eyewear manufacturers to produce large quantities of eye lenses, thus providing users with more affordable and diverse buying options. The integration of 3D printing technology with the eyewear manufacturing process further offers eyewear providers the opportunity to exercise efficient resource management and mitigate costs associated with extensive inventories, limited product design, and complicated supply chains.

The rising demand for customized eyewear among users is fueling the market growth. People prefer unique products that are tailored according to their needs, such as the shape of eyes and face, color and texture of glasses, and the frame's design and material. This is expected to result in the disruption of distribution models to meet end-users' demands, thus offering market growth opportunities over the next few years. To cater to this trend, an increasing number of eyewear manufacturers, such as Topology and Pair Eyewear, have started offering customized eyewear to their customers. These customized eyewear products include glasses with different features, such as eliminating UV radiation, photochromic glasses, and glasses with a high index number.

The amalgamation of digital channels with the eyewear value chain in recent years has increased the sales of eyewear products significantly. The e-commerce distribution channel is gradually gaining momentum due to the ongoing COVID-19 pandemic, which encourages users to practice social distancing and order from their homes. Several eyewear companies, including Lenskart, are offering users the opportunity to make calculated spectacle buying decisions by providing virtual facial analysis and product virtualization facilities. Additionally, establishing digital channels allows companies to maintain essential customer data such as their buying preferences, search history, and feedback, which can help them offer more curated and specific products to their customers in the future.

The emerging demand to practice sustainability among eyewear companies and their customers is changing the market dynamics. Eyewear manufacturers such as Evergreen Eyecare and Modo have started using eco-friendly materials in eyewear designs, which helps the company practice sustainable development and enhance its customer journey. The trend is encouraging newer eyewear manufacturers such as Shwood Eyewear and PaperStyle to diversify their products and offer more ecological, budget-friendly, and unique products to customers while also capture a better revenue share. Companies are experimenting with materials such as wood, paper, leather, and wool to design eyewear with innovative textures, which promises to attract more customers.

Request a free sample copy or view report summary: Eyewear Market Report

Eyewear Market Report Highlights

• In terms of product, the sunglasses segment is expected to emerge as the fastest-growing segment over the forecast period. The promising growth prospects of the segment can be attributed to the gradual easing of travel restrictions, which is promoting people to use sunglasses as a travel accessory.
• In terms of the distribution channel, the e-commerce segment is envisioned to register the highest growth rate over the forecast period. This can be attributed to the better functionality, ease of access, better discounts, and better buying options offered by online players.
• The Asia Pacific region is expected to register the highest CAGR over the forecast period. This can be chiefly attributed to the resumption of eyewear and eyewear parts manufacturing and essential supply chain activities in China, which is a major supplier of eyewear parts in the world.
• The growing demand for colored contact lenses and increasing penetration of soft contact lenses in Japan and China is further promoting the demand for eyewear in the Asia Pacific region.
• In response to the COVID-19 pandemic, companies rapidly deployed their IT capabilities to execute remote connections with employees and customers to deliver a productive and functional, and productive Work From Home (WFH) strategy, which has kept the market buoyant.

Eyewear Market Segmentation

Grand View Research has segmented the global eyewear market based on product, distribution channel, and region:

Eyewear Product Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

• Contact Lenses
  • Premium Contact Lenses
  • Mass Contact Lenses
• Spectacles
  • Spectacle Frame
    • Type
      • Premium Spectacle Frames
      • Mass Spectacle Frames
    • Style
      • Round
      • Square
      • Rectangle
      • Oval
      • Others
    • Spectacle Lenses
  • Sunglasses
    • Lens Type
      • Polarized Sunglasses
      • Non-Polarized Sunglasses
    • Lens Material
      • CR-39
      • Polycarbonate
      • Polyurethane
      • Others

Eyewear Distribution Channel Outlook (Revenue, USD Million, 2017 - 2028)

• E-Commerce
• Brick& Mortar

Eyewear Regional Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • Vietnam
• South America
  • Brazil
• MEA

List of Key Players in the Eyewear Market

• Johnson & Johnson Vision Care, Inc.
• ESSILORLUXOTTICA
• CooperVision
• Carl Zeiss AG.
• Bausch & Lomb Inc.
• Safilo Group S.p.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharmaceutical CMO And CRO Market Growth Factors, Demand, Opportunities, Current Trends & Predictions

 Biopharmaceutical CMO & CRO Market Growth & Trends

The global biopharmaceutical CMO and CRO market size is expected to reach USD 49.2 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2021 to 2028. The market is significantly driven by the growing interest of conventional drug developers in biological therapeutics. At present, outsourcing has become a cost-saving strategy for small to medium-sized bio-manufacturers as it helps in eliminating the need for establishing costly specialized facilities or hiring and training personnel.

The global market for biopharmaceutical CMO and CRO is expected to thrive during the pandemic owing to positive pipeline development across modalities. For instance, Lonza and Moderna announced a ten-year collaboration for the commercial manufacturing of the COVID-19 vaccine. Such developments compensated for minor delays in clinical trials that occurred during the first half of 2020. The contract manufacturing organization segment is projected to unlock lucrative growth opportunities over the foreseeable future.

The decline in R&D productivity and increased development costs have resulted in high pressure on biopharmaceutical manufacturers pertaining to short-term earnings and profit margins. This, in turn, has created lucrative opportunities for the CMOs and CROs to accelerate their business operations.

The mammalian source segment dominated the market in 2020. CMOs are engaged in standardizing their mammalian systems, thereby driving the revenue growth in the mammalian segment. Plant-based expression systems are developed and explored as a cost-effective alternative for the production of large molecules.

The robustness of venture capital investments is one of the important supportive factors that has created opportunities for the growth of CMOs. Venture capital funds are considered more reliable than public equity. An increase in the availability of venture funds for life sciences is expected to bolster the growth of CMOs.

However, these CMOs and CROs are facing competition from in-house departments of pharmaceutical and biotechnology companies. Several big pharma companies like Novartis announced to keep their biomanufacturing process in-house.

Some key CMOs are Lonza; Boehringer Ingelheim GmbH; Patheon; Samsung BioLogics; and FUJIFILM Diosynth Biotechnologies U.S.A., Inc. The key players are involved in establishing mutually beneficial alliances with other emerging CMOs to scale up their production capabilities.

Request a free sample copy or view report summary: Biopharmaceutical CMO & CRO Market Report

Biopharmaceutical CMO & CRO Market Report Highlights

• Based on source, mammalian cell line-based bioproduction system accounted for the largest revenue share of 54.0% in 2020 due to the growth in mammalian system titers and yields
• By service type, contract manufacturing services accounted for the largest share of 57.7% in 2020 owing to the presence of a wide range of services from cell line development to the final packaging of the product
• Contract research services are expected to expand at the fastest CAGR of 8.4% over the forecast period. This can be attributed to increasing investment in research programs for the development of novel therapeutics
• In terms of product, biologics held the largest share of 81.8% in 2020. In recent times, biologics manufacturing is becoming more specialized, as a result of which CMOs have become an integral part of the biologics production strategies of clients
• North America held the largest share of 33.8% in 2020. The North American biopharmaceutical research industry is recognized as a leader in biopharmaceutical innovations. Several biopharma companies from the U.S. are considering Asian countries for the development of pharma products. This is primarily due to the growing costs of R&D in their home country and the presence of low-cost production facilities and cheap labor in Asian countries

Biopharmaceutical CMO & CRO Market Segmentation

Grand View Research has segmented the global biopharmaceutical CMO and CRO market on the basis of source, service type, product, and region:

Biopharmaceutical CMO & CRO Source Outlook (Revenue, USD Million, 2016 - 2028)

• Mammalian
• Non-mammalian

Biopharmaceutical CMO & CRO Service Type Outlook (Revenue, USD Million, 2016 - 2028)

• Contract Manufacturing
  • Process Development
    • Downstream
    • Upstream
  • Fill & Finish Operations
  • Analytical & QC studies
  • Packaging
• Contract Research
  • Oncology
  • Inflammation & Immunology
  • Cardiology
  • Neuroscience
  • Others

Biopharmaceutical CMO & CRO Product Outlook (Revenue, USD Million, 2016 - 2028)

• Biologics
  • Monoclonal antibodies (MABs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi, & Molecular Therapy
  • Others
• Biosimilars

Biopharmaceutical CMO & CRO Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of the Biopharmaceutical CMO & CRO Market

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologie GmbH
• JRS PHARMA
• BIOMEVA GmbH
• ProBioGen
• FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
• TOYOBO CO., LTD.
• Samsung BioLogics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.    

Fitness App Market to Surpass USD 15.5 Billion by 2028: Grand View Research Inc.

 Fitness App Market Growth & Trends

The global fitness app market size is expected to reach USD 15.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 21.6% from 2021 to 2028. Rising health and fitness awareness and the growing prevalence of obesity are major factors driving the global market. According to the Centers for Disease Control and Prevention, the prevalence of obesity increased from 30.5% in 1999-2000 to 42.4% in 2017-2018. Moreover, awareness regarding obesity-related health conditions, including diabetes, stroke, heart diseases, and cancer, is increasing. This, in turn, is fueling the adoption of fitness apps to manage weight and aid weight loss.

The lockdown and social distancing norms by governments to control the spread of the COVID-19 virus have negatively impacted the gyms and fitness centers globally. However, consumers have shifted their focus to online fitness classes and apps. The total number of downloads and active users increased rapidly during the COVID-19 lockdown. For instance, the daily active users on fitness apps increased by 24% in Asia Pacific, 11% in Europe, 8% in Americas, and 28% in the Middle East and North Africa between quarter 1 and quarter 2 of 2020. Moreover, many fitness apps are witnessing an increase in their downloads and profits. For instance, HealthifyMe, an Indian fitness app, witnessed a 30% increase in traffic and a 40% increase in revenue in April 2020.

Moreover, a rise in the number of product launches, investments, collaborations, partnerships, and mergers & acquisitions is boosting the adoption of fitness apps in the market. For instance, in March 2020, Curefit, a health and fitness company, received USD 110 million in funding from Temasek Holdings Limited. In November 2020, Hong Kong Baptist University (HKBU) and The Chinese University of Hong Kong (CUHK) collaborated to launch MusFit Action Mobile App, which is focused on home-based exercises for elderly and middle-aged people. In December 2020, National Football League player DeMarcus Ware introduced his fitness app Driven to Win on Apple Store. The subscribers can work out with NBL players through this app. This app will be available for Android from 2021.

Request a free sample copy or view report summary: Fitness App Market Report

Fitness App Market Report Highlights

• The exercise and weight loss segment emerged as the leading type segment in 2020 with a revenue share of 54.7%
• By platform, iOS accounted for the largest revenue share in 2020. The Android segment is projected to expand at the fastest CAGR during the forecast period
• Based on the device, smartphones accounted for the largest revenue share in 2020. Wearable devices are projected to expand at the fastest CAGR during the forecast period
• North America accounted for the largest share in 2020 due to the increasing awareness regarding health and wellness, high penetration of smartphones, and availability of a large number of fitness apps

Fitness App Market Segmentation

Grand View Research has segmented the global fitness app market on the basis of type, platform, device, and region:

Fitness App Type Outlook (Revenue, USD Million, 2016 - 2028)

• Exercise & Weight Loss
• Diet & Nutrition
• Activity Tracking

Fitness App Platform Outlook (Revenue, USD Million, 2016 - 2028)

• Android
• iOS
• Others

Fitness App Device Outlook (Revenue, USD Million, 2016 - 2028)

• Smartphones
• Tablets
• Wearable Devices

Fitness App Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Fitness App Market

• Adidas
• Fitbit, Inc.
• Appster
• Azumio, Inc.
• MyFitnessPal Inc.
• Applico
• FitnessKeeper
• Aaptiv
• Nike
• Noom
• Under Armour, Inc.
• Appinventiv

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.